Your session is about to expire
← Back to Search
Mindfulness-based Intervention for Prostate Cancer (TEMPO Trial)
N/A
Waitlist Available
Led By Lindsey Herrel, MD, MS
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 3 and 6 months post-prostatectomy
Awards & highlights
TEMPO Trial Summary
This trial will test a mindfulness intervention to help ease distress for men undergoing prostatectomy and their partners.
Eligible Conditions
- Prostate Cancer
TEMPO Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline at 3 and 6 months post-prostatectomy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 3 and 6 months post-prostatectomy
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in level of distress assessed using the PROMIS SF Depression.
Change in level of distress assessed using the PROMIS SF Positive Affect and Well Being
Change in level of distress assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) Anxiety
Secondary outcome measures
Change in level of distress assessed using the 5-facet Mindfulness Questionnaire (FFMQ)
Change in level of distress assessed using the National Comprehensive Cancer Network (NCCN) Distress Thermometer
Change in salivary cortisol level (only patients will complete this, not partners)
+1 moreTEMPO Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Part 2: Couples-based mindfulness interventionExperimental Treatment2 Interventions
Mindfulness-based intervention + Usual care
Group II: Part 2: Usual careActive Control1 Intervention
Usual care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-based Intervention
2018
N/A
~780
Usual Care
1990
Completed Phase 4
~7700
Find a Location
Who is running the clinical trial?
University of Michigan Rogel Cancer CenterLead Sponsor
293 Previous Clinical Trials
24,096 Total Patients Enrolled
28 Trials studying Prostate Cancer
2,985 Patients Enrolled for Prostate Cancer
Lindsey Herrel, MD, MSPrincipal InvestigatorUniversity of Michigan
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger